Gene selection for microarray data analysis using principal component analysis.

Stat Med

Department of Biomathematics and Biostatistics, Georgetown University, Lombardi Cancer Center, 4000 Reservoir Road NW, Washington, DC 20057-1484, U.S.A.

Published: July 2005

Principal component analysis (PCA) has been widely used in multivariate data analysis to reduce the dimensionality of the data in order to simplify subsequent analysis and allow for summarization of the data in a parsimonious manner. It has become a useful tool in microarray data analysis. For a typical microarray data set, it is often difficult to compare the overall gene expression difference between observations from different groups or conduct the classification based on a very large number of genes. In this paper, we propose a gene selection method based on the strategy proposed by Krzanowski. We demonstrate the effectiveness of this procedure using a cancer gene expression data set and compare it with several other gene selection strategies. It turns out that the proposed method selects the best gene subset for preserving the original data structure.

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.2082DOI Listing

Publication Analysis

Top Keywords

gene selection
12
microarray data
12
data analysis
12
data
8
analysis principal
8
principal component
8
component analysis
8
data set
8
compare gene
8
gene expression
8

Similar Publications

Background: Baculoviruses are ideal biological insecticides, providing long-lasting pest control and environmental benefits. Alphabaculovirus mabrassicae stains, with their broad host range, have been effective in agricultural pest management. Various A.

View Article and Find Full Text PDF

Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation.

Hum Gene Ther

January 2025

Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

Cystic fibrosis (CF) is caused by mutations in the (). While gene therapy holds promise as a cure, the cell-type-specific heterogeneity of expression in the lung presents significant challenges. Current CF ferret models closely replicate the human disease phenotype but have limitations in studying functional complementation through cell-type-specific CFTR restoration.

View Article and Find Full Text PDF

Invading species along with increased anthropogenization may lead to hybridization events between wild species and closely related domesticates. As a consequence, wild species may carry introgressed alleles from domestic species, which is generally assumed to yield adverse effects in wild populations. The opposite evolutionary consequence, adaptive introgression, where introgressed genes are positively selected in the wild species, is possible but has rarely been documented.

View Article and Find Full Text PDF

Identification of Programmed Cell Death-related Biomarkers for the Potential Diagnosis and Treatment of Osteoporosis.

Endocr Metab Immune Disord Drug Targets

January 2025

Department of Orthopaedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Background: Osteoporosis (OP) is a skeletal condition characterized by increased susceptibility to fractures. Programmed cell death (PCD) is the orderly process of cells ending their own life that has not been thoroughly explored in relation to OP.

Objective: This study is to investigate PCD-related genes in OP, shedding light on potential mechanisms underlying the disease.

View Article and Find Full Text PDF

Effect of Oral Posaconazole on Venetoclax Plasma Concentration and its Efficacy in Patients with Acute Myeloid Leukemia.

Recent Pat Anticancer Drug Discov

January 2025

Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, P.R. China.

Background: BCL-2 was the first gene identified to have antiapoptotic effects, and venetoclax is an oral selective BCL-2 inhibitor, which has great potential in the treatment of patients with acute myeloid leukemia (AML) who are not candidates for intensive therapy. Notably, posaconazole, an oral antifungal drug, is also a strong factor that can affect blood venetoclax concentrations. To the best of our knowledge, the relationship between BCL-2 expression, posaconazole, and venetoclax, as well as their influence on treatment efficacy and the prognosis of patients with AML, has not been reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!